Cristina M. DeCesaris
( out of 63 reviews )

Cristina M. DeCesaris, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Radiation Oncology
Salt Lake City
801-581-2396

Sugar House Health Center

Salt Lake City
801-581-2000

  • Cristina DeCesaris, MD, a Huntsman Cancer Institute (HCI) physician, is a clinical track assistant professor in the Department of Radiation Oncology at the University of Utah. She is a member of the multidisciplinary Central Nervous System, Gynecology, and Pediatric teams.

    Dr. DeCesaris’s clinical expertise is in delivering intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), image guided radiation therapy (IGRT), volumetric modulated arc therapy (VMAT), proton pencil-beam scanning (PBS) radiotherapy, and high dose rate (HDR) brachytherapy.

    Dr. DeCesaris earned dual bachelor’s degrees in Neurobiology and Physiology as well as Psychology at The University of Maryland in College Park, MD. She went on to complete medical school at the Rutgers University’s Robert Wood Johnson School of Medicine and residency at the University of Maryland in Baltimore, MD. She is passionate about education, clinical research, and equitable delivery of healthcare. She is a member of many committees at the University of Utah. She is currently a member of many American Society for Radiation Oncology (ASTRO) and American Society of Clinical Oncology (ASCO), where she serves as a mentor training young physicians in critical review of medical literature. She is involved in prospective clinical trials and has completed clinical and database research.

    Specialties

    Patient Rating

    4.8 /5
    ( out of 63 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 05, 2024
    HUNTSMAN CANCER CENTER

    Dr. Decesaris is a straight shooter. Shows empathy but doesn't sugar-coat the situation or condescend.

    September 23, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr. DeCesaris is an excellent physician. Thorough in all ways.

    July 19, 2024
    HUNTSMAN CANCER CENTER

    Dr. Cristina Marie Decesaris is awesome. She cares about my child. She shows love and care toward my child.

    June 28, 2024
    HUNTSMAN CANCER CENTER

    Dr Decesaris is above and beyond any doctor I've ever experienced. Her compassion, her thoughtfulness, her thoroughness, the time she takes to explain everything...she even apologizes if she's late!!! Who does that??? She does! I wish I could hand-pick her for every one of my acquaintances who will ever need to undergo radiation treatment.

    June 15, 2024
    HUNTSMAN CANCER CENTER

    She is very caring, explains things carefully so you understand.

    June 13, 2024
    HUNTSMAN CANCER CENTER

    In all 64 years of my existence, I don't remember a provider more proactive or detail-oriented than Dr. DeCesaris. She is outstanding in every way. After some of the things I've faced on this journey, I can only say this was specifically ordered by God's loving hand (a divine appointment), for which I am incredibly grateful. She far exceeded my expectations, a credit to her integrity, diligence, obvious passion for her profession, and compassion for those she treats.

    June 02, 2024
    FARMINGTON HEALTH CENTER

    No personable skills and quite rude

    May 25, 2024
    HUNTSMAN CANCER CENTER

    Dr Decedaris, although busy, took time to council with me and made a medical suggestion.

    May 22, 2024
    HUNTSMAN CANCER CENTER

    Very kind. Always respectful of your feelings. Dr. Decesaris wants to stay on top of your care. Feel safe in her care.

    See More Patient Comments

  • Cristina DeCesaris, MD, a Huntsman Cancer Institute (HCI) physician, is a clinical track assistant professor in the Department of Radiation Oncology at the University of Utah. She is a member of the multidisciplinary Central Nervous System, Gynecology, and Pediatric teams.

    Dr. DeCesaris’s clinical expertise is in delivering intensity modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), stereotactic radiosurgery (SRS), image guided radiation therapy (IGRT), volumetric modulated arc therapy (VMAT), proton pencil-beam scanning (PBS) radiotherapy, and high dose rate (HDR) brachytherapy.

    Dr. DeCesaris earned dual bachelor’s degrees in Neurobiology and Physiology as well as Psychology at The University of Maryland in College Park, MD. She went on to complete medical school at the Rutgers University’s Robert Wood Johnson School of Medicine and residency at the University of Maryland in Baltimore, MD. She is passionate about education, clinical research, and equitable delivery of healthcare. She is a member of many committees at the University of Utah. She is currently a member of many American Society for Radiation Oncology (ASTRO) and American Society of Clinical Oncology (ASCO), where she serves as a mentor training young physicians in critical review of medical literature. She is involved in prospective clinical trials and has completed clinical and database research.

    Board Certification and Academic Information

    Academic Departments Radiation Oncology -Primary

    Education history

    Professional Other ASCO Journals Editorial Fellow Fellow
    Residency Radiation Oncology - University of Maryland Medical Center Resident
    Chief Resident Radiation Oncology - University of Maryland Medical Center Chief Resident
    Residency Radiation Oncology - University of Maryland Medical Center Resident
    Internship Internal Medicine - Lankenau Medical Center Intern
    Fellowship Radiation Oncology - Perelman School of Medicine at the University of Pennsylvania Clinical Research Fellow
    Professional Medical Medicine - Rutgers Robert Wood Johnson Medical School M.D.
    Undergraduate Neurobiology/Physiology - University of Maryland B.S.
    Undergraduate Psychology - University of Maryland B.S.

    Selected Publications

    Journal Article

    1. Gravbrot N, Rock CB, Weil CR, Rock CB, Burt LM, DeCesaris CM, Jensen RL, Shrieve DC, Cannon DM (2024). Gross tumor and intracranial control benefits with fractionated radiotherapy compared to stereotactic radiosurgery for patients with WHO grade 2 meningioma. World Neurosurg. (Read full article)
    2. Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt LM (2024). Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer. Eur J Cancer, 201, 113913. (Read full article)
    3. Rock CB, Weil CR, Rock CB, Gravbrot N, Burt LM, DeCesaris C, Menacho ST, Jensen RL, Shrieve DC, Cannon DM (2024). Patterns of failure after radiosurgery for WHO grade 1 or imaging defined meningiomas: Long-term outcomes and implications for management. J Clin Neurosci, 120, 175-180. (Read full article)
    4. Huang YJ, DeCesaris CM, Sarkar V, Zhao H, Kunz J, Nelson G, Li X, Suneja G, Burt LM, Gaffney DK (2023). Image-guided preplanning workflow for high-dose-rate interstitial brachytherapy for gynecological malignancies. Brachytherapy, 23(1), 25-34. (Read full article)
    5. Lee SS, Weil CR, Boyd LR, DeCesaris C, Gaffney D, Suneja G (2023). Trends in use of radiation therapy, chemotherapy, and combination chemoradiotherapy in advanced uterine cancer before, during, and after GOG 258. Int J Gynecol Cancer, 33(9), 1408-1418. (Read full article)
    6. DeCesaris CM, Mossahebi S, Jatczak J, Rao AD, Zhu M, Mishra MV, Nichols E (2021). Outcomes of and treatment planning considerations for a hybrid technique delivering proton pencil-beam scanning radiation to women with metal-containing tissue expanders undergoing post-mastectomy radiation. Radiother Oncol, 164, 289-298. (Read full article)
    7. DeCesaris CM, Pollock A, Zhang B, Poirier Y, Kowalski E, Paulosky K, Mishra MV, Nichols E (2020). Assessing the Need for Adjusted Organ-at-Risk Planning Goals for Patients Undergoing Adjuvant Radiation Therapy for Locally Advanced Breast Cancer with Proton Radiation. Pract Radiat Oncol, 11(2), 108-118. (Read full article)
    8. Moran BJ, Koroulakis A, DeCesaris C, Braccioforte MH, Amin N, Agarwal M (2020). Long-term outcomes of a prospective randomized trial of 131Cs/125I permanent prostate brachytherapy. Brachytherapy, 20(1), 38-43. (Read full article)
    9. Snider JW, Molitoris J, Shyu S, Diwanji T, Rice S, Kowalski E, DeCesaris C, Remick JS, Yi B, Zhang B, Hall A, Hanna N, Ng VY, Regine WF (2020). Spatially Fractionated Radiotherapy (GRID) Prior to Standard Neoadjuvant Conventionally Fractionated Radiotherapy for Bulky, High-Risk Soft Tissue and Osteosarcomas: Feasibility, Safety, and Promising Pathologic Response Rates. Radiat Res, 194(6), 707-714. (Read full article)
    10. Poirier Y, Becker S, DeCesaris C, Culberson W, Draeger E, Gerry AJ, Johnstone CD, Gibbs A, Vujaskovic Z, Jackson IL (2020). The Impact of Radiation Energy on Dose Homogeneity and Organ Dose in the Göttingen Minipig Total-Body Irradiation Model. Radiat Res, 194(5), 544-556. (Read full article)
    11. DeCesaris C, Rao AD (2020). Characterizing the Risk of Vertebral Body Fractures in Patients Receiving Chemoradiotherapy for Esophageal Cancer. JAMA Netw Open, 3(9), e2014340. (Read full article)
    12. DeCesaris CM, Berger M, Choi JI, Carr SR, Burrows WM, Regine WF, Simone CB 2nd, Molitoris JK (2020). Pathologic complete response (pCR) rates and outcomes after neoadjuvant chemoradiotherapy with proton or photon radiation for adenocarcinomas of the esophagus and gastroesophageal junction. J Gastrointest Oncol, 11(4), 663-673. (Read full article)
    13. DeCesaris CM, McCarroll R, Mishra MV, Glass E, Greenwald BD, Carr S, Burrows W, Mehra R, Regine WF, Simone CB 2nd, Choi JI, Molitoris JK (2020). Assessing Outcomes of Patients Treated With Re-Irradiation Utilizing Proton Pencil-Beam Scanning for Primary or Recurrent Malignancies of the Esophagus and Gastroesophageal Junction. J Thorac Oncol, 15(6), 1054-1064. (Read full article)
    14. Zhu M, Kaiser A, Mishra MV, Kwok Y, Remick J, DeCesaris C, Langen KM (2019). Multiple Computed Tomography Robust Optimization to Account for Random Anatomic Density Variations During Intensity Modulated Proton Therapy. Adv Radiat Oncol, 5(5), 1022-1031. (Read full article)
    15. Koroulakis A, Rice SR, DeCesaris C, Knight N, Nichols EM (2019). Perceptions and Patterns in Academic Publishing: A Survey of United States Residents in Radiation Oncology. Adv Radiat Oncol, 5(2), 146-151. (Read full article)
    16. Chinniah C, Aguarin L, Cheng P, DeCesaris C, Cutillo A, Berman AT, Frick M, Doucette A, Cengel KA, Levin W, Hahn S, Dorsey JF, Simone CB 2nd, Kao GD (2019). Early Detection of Recurrence in Patients With Locally Advanced Non-Small-Cell Lung Cancer via Circulating Tumor Cell Analysis. Clin Lung Cancer, 20(5), 384-390.e2. (Read full article)
    17. DeCesaris CM, Rice SR, Bentzen SM, Jatczak J, Mishra MV, Nichols EM (2019). Quantification of Acute Skin Toxicities in Patients With Breast Cancer Undergoing Adjuvant Proton versus Photon Radiation Therapy: A Single Institutional Experience. Int J Radiat Oncol Biol Phys, 104(5), 1084-1090. (Read full article)
    18. Frick MA, Kao GD, Aguarin L, Chinniah C, Swisher-McClure S, Berman AT, Levin WP, Cengel KA, DeCesaris C, Hahn SM, Dorsey JF, Simone CB 2nd (2018). Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study. Int J Radiat Oncol Biol Phys, 102(3), 536-542. (Read full article)
    19. Berman AT, DeCesaris CM, Simone CB 2nd, Vachani C, DiLullo G, Hampshire MK, Metz J, Hill-Kayser C (2016). Use of Survivorship Care Plans and Analysis of Patient-Reported Outcomes in Multinational Patients With Lung Cancer. J Oncol Pract, 12(5), e527-35. (Read full article)

    Case Report

    1. DeCesaris C, Amin NP, Hundal J, Vujaskovic Z, Agarwal M (2018). Hyperthermia and Hyper-fractionated Radiation for a Cutaneous Squamous Cell Carcinoma Progressing on Standard Therapy: A Case Report. Adv Radiat Oncol, 4(1), 4-9. (Read full article)

    Letter

    1. DeCesaris CM, Kokeny K (2022). The Best Defense is a Good Offense. [Letter to the editor]. Int J Radiat Oncol Biol Phys, 114(4), 574-575. (Read full article)
    2. DeCesaris C, Rice SR, Bentzen SM, Jatczak J, Mishra MV, Mossahebi S, Nichols EM (2019). In Reply to Tommasino et al. [Letter to the editor]. Int J Radiat Oncol Biol Phys, 105(3), 677-678. (Read full article)

    Other

    1. Gravbrot N, Weil CR, DeCesaris CM, Gaffney DK, Suneja G, Burt LM (2024). Corrigendum to "Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer" Eur. J. Cancer (201) (April) 2024, 113913. Eur J Cancer (202, p. 114017). England. (Read full article)

  • Clinical Trials